Phase I single-dose trial of TRV 1200274 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 11 Sep 2012
At a glance
- Drugs TRV 027 (Primary)
- Indications Decompensated heart failure
- Focus Adverse reactions; Pharmacokinetics
- 11 Sep 2012 Results were presented at the 16th Annual Meeting of the Heart Failure Society of America.
- 20 Apr 2010 New trial record
- 15 Apr 2010 Status changed from not yet recruiting to recruiting, according to a Trevena media release.